This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (41)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

JOSEPH IGERSHEIMER, M.D.

AMA Arch Ophthalmol. 1955;53(1):94-104.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

PROGRESSVIE exophthalmos is often called "malignant" exophthalmos, and it is sometimes referred to as exophthalmic ophthalmoplegia (Brain¹²), thyrotropic exophthalmos (Mulvany¹⁸), and a hyperophthalmopathic type of Graves's disease (Means¹⁶). In contrast to the slight exophthalmos of goiter, which may be combined with some staring, the malignant type is characterized by its progressive nature; periorbital and lid edema; diminution or lack of resiliency, elicited by palpating the eyeball; limitation of ocular motility, often causing diplopia, and retraction of the upper lid, resulting in staring. In some cases thyrotoxicosis precedes this exophthalmos, but usually by the time there are signs of progressive exophthalmos the thyroid condition is well controlled or has reached the stage of hypothyroidism; occasionally there is no thyroid history whatsoever. Fortunately, malignant exophthalmos occurs infrequently, for it is a disabling and dangerous disease and a great burden to the patient, as well as to the physician, particularly . . . [Full Text PDF of this Article]

Author Affiliations
BOSTON

Associate at Tufts College Medical School.

Footnotes
Read before the Section on Ophthalmology at the 103rd Annual Meeting of the American Medical Association, San Francisco, June 24, 1954.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?